Zepbound tops Wegovy for weight loss in Eli Lilly study ...Middle East

News10NBC - News
Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk. Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% for Wegovy. The drugmaker also said more patients taking Zepbound achieved at least 25% weight loss. The study results should help fuel Zepbound’s accelerating market-share gains, Leerink Partners analyst David Risinger said in a research note. The drug brought in $1.3 billion in sales for Lilly in this year’s third quarter, less than a year after it hit the market. The study monitored 751 people

Read More Details
Finally We wish PressBee provided you with enough information of ( Zepbound tops Wegovy for weight loss in Eli Lilly study )

Also on site :